Hikma Pharmaceutical | HIK - El Costo De Ventas





El Costo De Ventas Cambio Fecha
Almirall EUR 191.5M 2.29M 2025-12
argenx SE USD 121M 28.69M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Autolus Therapeutics Ltd USD 24.57M 762K 2026-03
Bayer EUR 5.23B 731M 2026-03
Fresenius EUR 4.45B 262M 2025-12
Genmab DKK 81M 23M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
GRIFOLS EUR 1.08B 214.82M 2026-03
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.07B 219M 2026-03
Orion EUR 163.7M 22.9M 2026-03
Recordati EUR 202.6M 13.03M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
UCB EUR 1.07B 146M 2025-12